A Splice of Life Science Marketing Podcast

Ep 10: How to Market RUO Products Without Triggering FDA Oversight

Written by Matt Wilkinson | Mar 29, 2026 1:44:00 PM

Learn the exact phrases that trigger FDA scrutiny when marketing Research Use Only products—and what to say instead.

 

Shownotes

Your antibody copy could land you an FDA warning letter. One wrong phrase on your website transforms a research tool into an unapproved diagnostic device in the eyes of regulators.

This conversation is for marketing managers at life science tools companies who need to promote Research Use Only (RUO) products without crossing regulatory lines. Josh Levin, former FDA compliance officer and diagnostics consultant, explains exactly which words trigger investigations and how to communicate analytical performance without implying diagnostic intent. Words matter: phrases like "used in diagnosis" or "detects disease" create regulatory risk; safer language references literature findings or analytical capabilities.

What you will learn:

  • The specific RUO disclaimer language FDA requires and where it must appear
  • Red flag phrases that imply diagnostic claims versus safe alternatives that reference published research
  • Why written website copy receives more FDA scrutiny than verbal sales conversations
  • How to present clinical data and analytical performance without crossing into diagnostic territory
  • What compliance language belongs in distributor agreements to prevent off-label promotion
  • Three strategic tips for tools companies considering entry into the diagnostic space

Chapters:

  • [0:00] Introduction and defining Research Use Only
  • [1:26] What RUO means and how FDA determines intended use
  • [2:29] Required RUO statement placement and formatting
  • [3:58] What manufacturers can and cannot say about RUO products
  • [6:35] Red flag words versus safe phrasing for website copy
  • [9:23] Framing analytical data without implying clinical validity
  • [12:01] Application notes and case study guardrails
  • [13:09] How AI might change FDA compliance monitoring
  • [14:24] Working with diagnostic and clinical lab customers
  • [21:38] Distributor compliance and partner training
  • [22:51] Combined-function instruments and software considerations
  • [26:13] Three tips for tools companies entering diagnostics

Keywords: Research Use Only, RUO products, FDA compliance, life science marketing, diagnostic claims, regulatory copywriting, antibody marketing, lab developed tests, ISO 13485, clinical lab regulations, tools manufacturer compliance, FDA warning letters

Ready to ensure your marketing copy stays compliant? Watch this essential conversation, subscribe for more regulatory insights, and visit strivenn.com for expert guidance on life science marketing strategy.